Cargando…

Pregnane X receptor activation remodels glucose metabolism to promote NAFLD development in obese mice

OBJECTIVE: Both obesity and exposure to chemicals may induce non-alcoholic fatty liver disease (NAFLD). Pregnane X Receptor (PXR) is a central target of metabolism disrupting chemicals and disturbs hepatic glucose and lipid metabolism. We hypothesized that the metabolic consequences of PXR activatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Karpale, Mikko, Kummu, Outi, Kärkkäinen, Olli, Lehtonen, Marko, Näpänkangas, Juha, Herfurth, Uta M., Braeuning, Albert, Rysä, Jaana, Hakkola, Jukka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10415798/
https://www.ncbi.nlm.nih.gov/pubmed/37467962
http://dx.doi.org/10.1016/j.molmet.2023.101779
_version_ 1785087625096331264
author Karpale, Mikko
Kummu, Outi
Kärkkäinen, Olli
Lehtonen, Marko
Näpänkangas, Juha
Herfurth, Uta M.
Braeuning, Albert
Rysä, Jaana
Hakkola, Jukka
author_facet Karpale, Mikko
Kummu, Outi
Kärkkäinen, Olli
Lehtonen, Marko
Näpänkangas, Juha
Herfurth, Uta M.
Braeuning, Albert
Rysä, Jaana
Hakkola, Jukka
author_sort Karpale, Mikko
collection PubMed
description OBJECTIVE: Both obesity and exposure to chemicals may induce non-alcoholic fatty liver disease (NAFLD). Pregnane X Receptor (PXR) is a central target of metabolism disrupting chemicals and disturbs hepatic glucose and lipid metabolism. We hypothesized that the metabolic consequences of PXR activation may be modified by existing obesity and associated metabolic dysfunction. METHODS: Wildtype and PXR knockout male mice were fed high-fat diet to induce obesity and metabolic dysfunction. PXR was activated with pregnenolone-16α-carbonitrile. Glucose metabolism, hepatosteatosis, insulin signaling, glucose uptake, liver glycogen, plasma and liver metabolomics, and liver, white adipose tissue, and muscle transcriptomics were investigated. RESULTS: PXR activation aggravated obesity-induced liver steatosis by promoting lipogenesis and inhibiting fatty acid disposal. Accordingly, hepatic insulin sensitivity was impaired and circulating alanine aminotransferase level increased. Lipid synthesis was facilitated by increased liver glucose uptake and utilization of glycogen reserves resulting in dissociation of hepatosteatosis and hepatic insulin resistance from the systemic glucose tolerance and insulin sensitivity. Furthermore, glucagon-induced hepatic glucose production was impaired. PXR deficiency did not protect from the metabolic manifestations of obesity, but the liver transcriptomics and metabolomics profiling suggest diminished activation of inflammation and less prominent changes in the overall metabolite profile. CONCLUSIONS: Obesity and PXR activation by chemical exposure have a synergistic effect on NAFLD development. To support liver fat accumulation the PXR activation reorganizes glucose metabolism that seemingly improves systemic glucose metabolism. This implies that obese individuals, already predisposed to metabolic diseases, may be more susceptible to harmful metabolic effects of PXR-activating drugs and environmental chemicals.
format Online
Article
Text
id pubmed-10415798
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-104157982023-08-12 Pregnane X receptor activation remodels glucose metabolism to promote NAFLD development in obese mice Karpale, Mikko Kummu, Outi Kärkkäinen, Olli Lehtonen, Marko Näpänkangas, Juha Herfurth, Uta M. Braeuning, Albert Rysä, Jaana Hakkola, Jukka Mol Metab Original Article OBJECTIVE: Both obesity and exposure to chemicals may induce non-alcoholic fatty liver disease (NAFLD). Pregnane X Receptor (PXR) is a central target of metabolism disrupting chemicals and disturbs hepatic glucose and lipid metabolism. We hypothesized that the metabolic consequences of PXR activation may be modified by existing obesity and associated metabolic dysfunction. METHODS: Wildtype and PXR knockout male mice were fed high-fat diet to induce obesity and metabolic dysfunction. PXR was activated with pregnenolone-16α-carbonitrile. Glucose metabolism, hepatosteatosis, insulin signaling, glucose uptake, liver glycogen, plasma and liver metabolomics, and liver, white adipose tissue, and muscle transcriptomics were investigated. RESULTS: PXR activation aggravated obesity-induced liver steatosis by promoting lipogenesis and inhibiting fatty acid disposal. Accordingly, hepatic insulin sensitivity was impaired and circulating alanine aminotransferase level increased. Lipid synthesis was facilitated by increased liver glucose uptake and utilization of glycogen reserves resulting in dissociation of hepatosteatosis and hepatic insulin resistance from the systemic glucose tolerance and insulin sensitivity. Furthermore, glucagon-induced hepatic glucose production was impaired. PXR deficiency did not protect from the metabolic manifestations of obesity, but the liver transcriptomics and metabolomics profiling suggest diminished activation of inflammation and less prominent changes in the overall metabolite profile. CONCLUSIONS: Obesity and PXR activation by chemical exposure have a synergistic effect on NAFLD development. To support liver fat accumulation the PXR activation reorganizes glucose metabolism that seemingly improves systemic glucose metabolism. This implies that obese individuals, already predisposed to metabolic diseases, may be more susceptible to harmful metabolic effects of PXR-activating drugs and environmental chemicals. Elsevier 2023-07-17 /pmc/articles/PMC10415798/ /pubmed/37467962 http://dx.doi.org/10.1016/j.molmet.2023.101779 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Karpale, Mikko
Kummu, Outi
Kärkkäinen, Olli
Lehtonen, Marko
Näpänkangas, Juha
Herfurth, Uta M.
Braeuning, Albert
Rysä, Jaana
Hakkola, Jukka
Pregnane X receptor activation remodels glucose metabolism to promote NAFLD development in obese mice
title Pregnane X receptor activation remodels glucose metabolism to promote NAFLD development in obese mice
title_full Pregnane X receptor activation remodels glucose metabolism to promote NAFLD development in obese mice
title_fullStr Pregnane X receptor activation remodels glucose metabolism to promote NAFLD development in obese mice
title_full_unstemmed Pregnane X receptor activation remodels glucose metabolism to promote NAFLD development in obese mice
title_short Pregnane X receptor activation remodels glucose metabolism to promote NAFLD development in obese mice
title_sort pregnane x receptor activation remodels glucose metabolism to promote nafld development in obese mice
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10415798/
https://www.ncbi.nlm.nih.gov/pubmed/37467962
http://dx.doi.org/10.1016/j.molmet.2023.101779
work_keys_str_mv AT karpalemikko pregnanexreceptoractivationremodelsglucosemetabolismtopromotenaflddevelopmentinobesemice
AT kummuouti pregnanexreceptoractivationremodelsglucosemetabolismtopromotenaflddevelopmentinobesemice
AT karkkainenolli pregnanexreceptoractivationremodelsglucosemetabolismtopromotenaflddevelopmentinobesemice
AT lehtonenmarko pregnanexreceptoractivationremodelsglucosemetabolismtopromotenaflddevelopmentinobesemice
AT napankangasjuha pregnanexreceptoractivationremodelsglucosemetabolismtopromotenaflddevelopmentinobesemice
AT herfurthutam pregnanexreceptoractivationremodelsglucosemetabolismtopromotenaflddevelopmentinobesemice
AT braeuningalbert pregnanexreceptoractivationremodelsglucosemetabolismtopromotenaflddevelopmentinobesemice
AT rysajaana pregnanexreceptoractivationremodelsglucosemetabolismtopromotenaflddevelopmentinobesemice
AT hakkolajukka pregnanexreceptoractivationremodelsglucosemetabolismtopromotenaflddevelopmentinobesemice